What is the current valuation of the US Lancet Pen Needles Market?

The market valuation was 581.22 USD Million in 2024. Read More

What is the projected market size for the US Lancet Pen Needles Market by 2035?

The market is expected to reach 1701.0 USD Million by 2035. Read More

What is the expected CAGR for the US Lancet Pen Needles Market during the forecast period?

The expected CAGR for the market from 2025 to 2035 is 10.25%. Read More

Which companies are the key players in the US Lancet Pen Needles Market?

Key players include Becton Dickinson and Company, Novo Nordisk A/S, and Sanofi S.A. Read More

What are the primary applications of lancet pen needles in the market?

The primary applications include Diabetes Management, Blood Glucose Monitoring, and Insulin Delivery. Read More

How do the sales of lancet pen needles vary by end-use segment?

Sales are distributed across Hospitals, Home Care Settings, Clinics, and Pharmacies. Read More

What types of lancet pen needles are available in the market?

The market offers Standard, Safety, and Adjustable Lancet Pen Needles. Read More

What distribution channels are utilized for lancet pen needles?

Distribution channels include Online Retail, Pharmaceutical Retail, and Medical Supply Stores. Read More

What materials are commonly used in the production of lancet pen needles?

Common materials include Plastic, Metal, and Silicone. Read More

How does the market performance of lancet pen needles in 2024 compare to projections for 2035?

The market is projected to grow from 581.22 USD Million in 2024 to 1701.0 USD Million by 2035. Read More

US Lancet Pen Needles Market

ID: MRFR/MED/11797-HCR

100 Pages

Rahul Gotadki

Last Updated: April 06, 2026

United States Lancet Pen Needles Market Research Report: Size, Share, Trend Analysis - Growth & Industry Forecast 2025 To 2035

US Lancet Pen Needles Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)10.25%

2024 Market Size$ 581.22 Million

2025 Market Size$ 647.1 Million

2035 Market Size$ 1,701 Million

Key Players

Becton Dickinson and Company

Novo Nordisk A/S

Sanofi S.A.

Roche Holding AG

Medtronic plc

Terumo Corporation

Trends

Technological Advancements in Needle Design
Increased Regulatory Scrutiny
Growing Awareness of Safe Disposal Practices

Opportunities

Growing Aging Population
Rising Prevalence of Diabetes
Increased Focus on Preventive Healthcare

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Diabetes Management
  2. 4.1.2 Blood Glucose Monitoring
  3. 4.1.3 Insulin Delivery
  4. 4.1.4 Cholesterol Testing
2. 4.2 Healthcare, BY End Use (USD Million)
  1. 4.2.1 Hospitals
  2. 4.2.2 Home Care Settings
  3. 4.2.3 Clinics
  4. 4.2.4 Pharmacies
3. 4.3 Healthcare, BY Product Type (USD Million)
  1. 4.3.1 Standard Lancet Pen Needles
  2. 4.3.2 Safety Lancet Pen Needles
  3. 4.3.3 Adjustable Lancet Pen Needles
4. 4.4 Healthcare, BY Distribution Channel (USD Million)
  1. 4.4.1 Online Retail
  2. 4.4.2 Pharmaceutical Retail
  3. 4.4.3 Medical Supply Stores
5. 4.5 Healthcare, BY Material Type (USD Million)
  1. 4.5.1 Plastic
  2. 4.5.2 Metal
  3. 4.5.3 Silicone
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Becton Dickinson and Company (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Novo Nordisk A/S (DK)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Sanofi S.A. (FR)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Roche Holding AG (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Medtronic plc (IE)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Terumo Corporation (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Abbott Laboratories (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eli Lilly and Company (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY END USE
4. 6.4 US MARKET ANALYSIS BY PRODUCT TYPE
5. 6.5 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
6. 6.6 US MARKET ANALYSIS BY MATERIAL TYPE
7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF HEALTHCARE
10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
13. 6.13 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
14. 6.14 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
15. 6.15 HEALTHCARE, BY END USE, 2024 (% SHARE)
16. 6.16 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
17. 6.17 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
18. 6.18 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
19. 6.19 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
20. 6.20 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
21. 6.21 HEALTHCARE, BY MATERIAL TYPE, 2024 (% SHARE)
22. 6.22 HEALTHCARE, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
  2. 7.2.2 BY END USE, 2026-2035 (USD Million)
  3. 7.2.3 BY PRODUCT TYPE, 2026-2035 (USD Million)
  4. 7.2.4 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Million)
  5. 7.2.5 BY MATERIAL TYPE, 2026-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Lancet Pen Needles Market Segmentation

US Lancet Pen Needles Market By Application (USD Million, 2026-2035)

Diabetes Management
Blood Glucose Monitoring
Insulin Delivery
Cholesterol Testing

US Lancet Pen Needles Market By End Use (USD Million, 2026-2035)

Hospitals
Home Care Settings
Clinics
Pharmacies

US Lancet Pen Needles Market By Product Type (USD Million, 2026-2035)

Standard Lancet Pen Needles
Safety Lancet Pen Needles
Adjustable Lancet Pen Needles

US Lancet Pen Needles Market By Distribution Channel (USD Million, 2026-2035)

Online Retail
Pharmaceutical Retail
Medical Supply Stores

US Lancet Pen Needles Market By Material Type (USD Million, 2026-2035)

Plastic
Metal
Silicone

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”